Literature DB >> 20535717

Physicians' knowledge and attitudes regarding implantable cardioverter-defibrillators.

Saadia Sherazi1, Wojciech Zareba, James P Daubert, Scott McNitt, Abrar H Shah, Mehmet K Aktas, Robert C Block.   

Abstract

BACKGROUND: Information is limited regarding the knowledge and attitudes of physicians typically involved in the referral of patients for implantable cardioverter-defibrillator (ICD) implantation.
METHODS: We conducted a survey of primary care physicians and cardiologists at the University of Rochester Medical Center and the Unity Health System Rochester, NY from December 2008 to February 2009. The survey collected information regarding physicians' knowledge of and attitudes towards ICD therapy.
RESULTS: Of the 332 surveys distributed, 110 (33%) were returned. Over-all 94 (87%) physicians reported referring patients for ICD implantation. Eighteen (17%) physicians reported unawareness of guidelines for ICD use. Sixty-four (59%) physicians recommended ICD in patients with ischemic cardiomyopathy and left ventricular ejection fraction (LVEF) < or = 35%. Sixty-five (62%) physicians use < or = 35% as the LVEF criterion for ICD referral in patients with non-ischemic cardiomyopathy. Cardiologists were more familiar than primary care physicians with LVEF criteria for implantation of ICD in patients with ischemic and non-ischemic cardiomyopathy (p value 0.005 and 0.002, respectively). Twenty-nine (27%) participants were unsure regarding the benefits of ICDs in eligible women and blacks. Eighty two (76%) physicians believed that an ICD could benefit patients > or = 70 years old, whereas only 53 (49%) indicated that an ICD would benefit patients > or = 80.
CONCLUSIONS: A lack of familiarity with current clinical guidelines regarding ICD implantation exists. Primary care physicians are less aware of clinical guidelines than are cardiologists. This finding highlights the need to improve the dissemination of guidelines to primary care physicians in an effort to improve ICD utilization.

Entities:  

Mesh:

Year:  2010        PMID: 20535717      PMCID: PMC3337764     

Source DB:  PubMed          Journal:  Cardiol J        ISSN: 1898-018X            Impact factor:   2.737


  26 in total

1.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

2.  Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction.

Authors:  G D Sanders; M A Hlatky; N R Every; K M McDonald; P A Heidenreich; L S Parsons; D K Owens
Journal:  Ann Intern Med       Date:  2001-11-20       Impact factor: 25.391

3.  The dissemination of new medical information.

Authors:  J K Stross; W R Harlan
Journal:  JAMA       Date:  1979-06-15       Impact factor: 56.272

4.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators.

Authors:  A J Moss; W J Hall; D S Cannom; J P Daubert; S L Higgins; H Klein; J H Levine; S Saksena; A L Waldo; D Wilber; M W Brown; M Heo
Journal:  N Engl J Med       Date:  1996-12-26       Impact factor: 91.245

5.  Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction.

Authors:  J Z Ayanian; P J Hauptman; E Guadagnoli; E M Antman; C L Pashos; B J McNeil
Journal:  N Engl J Med       Date:  1994-10-27       Impact factor: 91.245

6.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.

Authors:  A E Buxton; K L Lee; J D Fisher; M E Josephson; E N Prystowsky; G Hafley
Journal:  N Engl J Med       Date:  1999-12-16       Impact factor: 91.245

7.  Quality of life in the Canadian Implantable Defibrillator Study (CIDS).

Authors:  Jane Irvine; Paul Dorian; Brian Baker; Bernie J O'Brien; Robin Roberts; Michael Gent; David Newman; Stuart J Connolly
Journal:  Am Heart J       Date:  2002-08       Impact factor: 4.749

8.  Outcome of out-of-hospital cardiac arrest in New York City. The Pre-Hospital Arrest Survival Evaluation (PHASE) Study.

Authors:  G Lombardi; J Gallagher; P Gennis
Journal:  JAMA       Date:  1994-03-02       Impact factor: 56.272

9.  Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure.

Authors:  Adrian F Hernandez; Gregg C Fonarow; Li Liang; Sana M Al-Khatib; Lesley H Curtis; Kenneth A LaBresh; Clyde W Yancy; Nancy M Albert; Eric D Peterson
Journal:  JAMA       Date:  2007-10-03       Impact factor: 56.272

10.  Racial differences in outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT): a comparison of whites versus blacks.

Authors:  Andrea M Russo; Gail E Hafley; Kerry L Lee; Nicholas J Stamato; Michael H Lehmann; Richard L Page; Teresa Kus; Alfred E Buxton
Journal:  Circulation       Date:  2003-06-23       Impact factor: 29.690

View more
  8 in total

1.  Referring physicians' discordance with the primary prevention implantable cardioverter-defibrillator guidelines: a national survey.

Authors:  Jorge M Castellanos; Lisa M Smith; Paul D Varosy; Christine Dehlendorf; Gregory M Marcus
Journal:  Heart Rhythm       Date:  2012-02-02       Impact factor: 6.343

2.  A roadmap for evaluating the use and value of durable ventricular assist device therapy.

Authors:  Sarah T Ward; Qixing Liang; Francis D Pagani; Min Zhang; Robert L Kormos; Keith D Aaronson; Andrew D Althouse; Brahmajee K Nallamothu; Donald S Likosky
Journal:  J Heart Lung Transplant       Date:  2017-06-23       Impact factor: 10.247

3.  Comparative Effectiveness of Implantable Cardioverter Defibrillators for Primary Prevention in Women.

Authors:  Emily P Zeitler; Anne S Hellkamp; Phillip J Schulte; Gregg C Fonarow; Adrian F Hernandez; Eric D Peterson; Gillian D Sanders; Clyde W Yancy; Sana M Al-Khatib
Journal:  Circ Heart Fail       Date:  2016-01       Impact factor: 8.790

Review 4.  ICD Implantation Practice Within Europe: How To Explain The Differences Beyond Economy?

Authors:  Baccillieri Maria Stella; Zorzi Alessandro
Journal:  J Atr Fibrillation       Date:  2015-10-31

Review 5.  Life-saving devices reach the end of life with heart failure.

Authors:  Daniel D Matlock; Lynne Warner Stevenson
Journal:  Prog Cardiovasc Dis       Date:  2012 Nov-Dec       Impact factor: 8.194

6.  Underutilization of Implantable Cardioverter Defibrillator in Primary Prevention of Sudden Cardiac Arrest.

Authors:  Umashankar Lakshmanadoss; Saadia Sherazi; Ashim Aggarwal; David Hsi; Mehmet K Aktas; James P Daubert; Abrar H Shah
Journal:  Cardiol Res       Date:  2011-01-20

7.  Physicians' knowledge and attitudes in Saudi Arabia regarding implantable cardiac defibrillators.

Authors:  Tariq Alhogbani; Fuad A Awwad; Abdullah S Aljasser
Journal:  J Saudi Heart Assoc       Date:  2017-06-08

Review 8.  Decision-making regarding primary prevention implantable cardioverter-defibrillators among older adults.

Authors:  Paul L Hess; Daniel D Matlock; Sana M Al-Khatib
Journal:  Clin Cardiol       Date:  2019-12-23       Impact factor: 2.882

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.